Should you buy the De La Rue share price (and its 10% yield) as the SFO launches probe?

A Serious Fraud Office probe is the latest problem facing De La Rue plc (LON: DLAR) and its investors. Is it worth a punt at current prices or should it be avoided at all costs?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s been a cruel, cruel summer for investors in banknote printer De La Rue (LSE: DLAR).

An absolutely disastrous trading update at the end of May set nerves jangling before Britons even started making preparations for the sunny season. Its share price fell a whopping 34% in a day to around 300p per share, but it’s not done dropping yet.

As if things weren’t bad enough for De La Rue, news broke on Tuesday that the Serious Fraud Office (SFO) is to launch an investigation into the business and associated individuals with regards to “suspected corruption” in South Sudan.

The news sent the shares hurtling back towards the 250p marker and to prices not seen since 2003.

Boardroom blitz

As one would expect, De La Rue — which prints currency bills in the African country — commented that “it is not possible to predict reliably what effect their outcome may have” given the early stage of investigations. What the probe does do, though, is raise the prospect of some severe financial penalties and a significant hurdle in the company’s search for a new chief executive.

As I said at the top of the piece, De La Rue had already shocked markets before the summer even kicked off, declaring a 78% pre-tax profit slump in the fiscal year to March and giving guidance that results would be “somewhat lower” next year too.

Chief executive Martin Sutherland elected to fall on his sword following this most recent profit warning, leaving a mountain to climb for his eventual successor and fresh questions over future strategy. However, the boardroom strife at De La Rue doesn’t end here.

Chairman Philip Rogerson has also announced plans to retire as part of the CEO succession process, but Crystal Amber is calling for his immediate removal at tomorrow’s upcoming AGM. The activist investor is embroiled in a very public spat with the company and its board over what it sees as the “payment of egregious bonuses for destruction of shareholder value, and also questions the appropriateness of allowing Rogerson to oversee Sutherland’s replacement.

Too much trouble

De La Rue shares are worth just a third of what they were five years ago, and it’s hard to see how the price can recover in an increasingly cashless society. As well as battling a backdrop of intense competition, the business is facing an uncertain future as technology steadily erodes the need for its banknotes.

To illustrate this point, in Britain alone, the number of payments using physical coins and bills fell a further 16% in 2018 to some 11bn transactions, according to UK Finance. The body expects the role of cash to keep plummeting as contactless and mobile payments take over — it estimates that cash, used for 28% of transactions in the UK today, will be responsible for just one in 10 in a decade’s time.

It doesn’t matter to me that De La Rue trades on a dirt-cheap forward P/E ratio of 6.8 times. Nor am I moved by its gigantic corresponding dividend yield of 10%. The huge internal and external battles it currently faces make it a risk too far in my opinion, and I’d much rather put my hard-earned investment cash to work elsewhere.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »